Immuron (IMRN) Operating Income (2016 - 2024)

Immuron (IMRN) recorded quarterly Operating Income of $1660259127.7 billion in Q4 2024, up 82189906661311.72% quarter-over-quarter from -$2.0 million in Q4 2023, and up 82189906661311.72% on a YoY basis from N/an in Q1 2024.

Immuron (IMRN) Operating Income (2016 - 2024) Analysis & Trends

Immuron's Operating Income history runs 9 years deep, the most recent figure standing at $1660259127.7 billion for Q4 2024.

  • In Q4 2024, Operating Income rose 82189906661311.72% year-over-year to $1660259127.7 billion; the TTM figure through Dec 2024 stood at $1660259127.7 billion (up 12453603716.31% YoY), while the FY2025 annual figure was -$3.5 million, up 8.95% from the prior year.
  • Operating Income was $1660259127.7 billion for Q4 2024 at Immuron, up from -$2.0 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $1660259127.7 billion in Q4 2024 to a low of -$13.3 billion in Q4 2021.
  • Historically, Operating Income has averaged $276709852.4 billion across 5 years, with a median of -$1.6 million in 2023.
  • The sharpest annual moves came in 2021 and 2024: Operating Income sank 23228043.34% in 2021, then jumped 82189906661311.72% in 2024.
  • A 5-year view of Operating Income shows it stood at -$57371.6 in 2020, then tumbled by 23228043.34% to -$13.3 billion in 2021, then jumped by 99.99% to -$1.9 million in 2022, then slipped by 4.33% to -$2.0 million in 2023, then surged by 82189906661311.72% to $1660259127.7 billion in 2024.
  • The last three Operating Income figures came in at $1660259127.7 billion (Q4 2024), -$2.0 million (Q4 2023), and -$1.2 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -32.68 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -19.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -15.76 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.14 Bn
9 Abivax 91.96 Bn 91.96 Bn - -65.83 Mn
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 1,660,259,127.73 Bn
Dec 31, 2023 -2.02 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -1.94 Mn
Dec 31, 2021 -13.33 Bn
Dec 31, 2020 -57,371.61
Dec 31, 2019 -15,191.40
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 3.84 Mn
Dec 31, 2016 2.56 Mn
Jun 30, 2016 4.33 Mn